PapersPMID:28443702
Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT · 3 months
- Dose studied, every finding
- six capsules daily (6 x 500 mg) for 12 weeks
- Population, every finding
- 46 adults with non-alcoholic fatty liver disease (21 males, 25 females), aged 20-60 years, BMI 24.9-40 kg/m2
What moved
How to read these marks →“Turmeric consumption decreased serum levels of glucose, insulin, HOMA-IR and leptin (by 1.22, 17.69, 19.48 and 21.33% respectively, p < 0.05 for all) over 12 weeks compared with those variables in the placebo group.”
- Decreases HOMA-IR
very limited
- Decreases serum leptin
very limited
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Patients with NAFLD aged 20-60 years old; turmeric powder capsules (six capsules daily, 500 mg turmeric powder each) versus placebo capsules, 12 weeks.
- Participants
- 46
- Comparator
- placebo
- Duration
- 84 days
- Endpoints measured
- 7